Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness

Nicole Shaver, Melanie Katz, Gideon Darko Asamoah, Lori Ann Linkins, Wael Abdelkader, Andrew Beck, Alexandria Bennett, Sarah E. Hughes, Maureen Smith, Mpho Begin, Doug Coyle, Thomas Piggott, Benjamin M. Kagina, Vivian Welch, Caroline Colijn, David J.D. Earn, Khaled El Emam, Jane Heffernan, Sheila F. O'Brien, Kumanan WilsonErin Collins, Tamara Navarro, Joseph Beyene, Isabelle Boutron, Dawn Bowdish, Curtis Cooper, Andrew Costa, Janet Curran, Lauren Griffith, Amy Hsu, Jeremy Grimshaw, Marc André Langlois, Xiaoguang Li, Anne Pham-Huy, Parminder Raina, Michele Rubini, Lehana Thabane, Hui Wang, Lan Xu, Melissa Brouwers, Tanya Horsley, John Lavis, Alfonso Iorio, Julian Little

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)6411-6418
Number of pages8
JournalVaccine
Volume41
Issue number43
DOIs
Publication statusPublished - Oct 13 2023

ASJC Scopus Subject Areas

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Keywords

  • COVID-19
  • Hybrid immunity
  • Living systematic review
  • long COVID
  • Omicron
  • SARS-CoV-2 variant

Fingerprint

Dive into the research topics of 'Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness'. Together they form a unique fingerprint.

Cite this